Key Drivers
- Strong Free Cash Flow
- Tax-Boosted Earnings
- Tightening Liquidity
AIAI Summary
COO is now an execution-recovery investment: strong free cash flow and a $3B buyback can support upside after the selloff, but investors should wait for proof that CooperVision's Q4 destocking is temporary and that sales-force and premium-lens gaps are not causing durable share loss.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Free Cash Flow
- •Tax-Boosted Earnings
- •Tightening Liquidity
COO's strong cash flow and improving valuation are offset by tax-boosted quarterly earnings, weakening liquidity, and meaningful intangible-asset risk.
Price Behavior
Key Price Behavior Insights:
- •Steep Monthly Decline
- •Sharp Breakdown
- •Oversold Stabilization
COO remains bearish over the last month after a 27% decline and sharp breakdown, with oversold conditions allowing a possible bounce but trend reversal requiring a move above the $65.51 average.
Sharp drop from $63.48 to $54.17 on 2026-09-10
Sentiment & News
Key News Insights:
- •Guidance reduced
- •Inventory pressure
- •Legal scrutiny
CooperCompanies beat earnings but cut growth guidance amid CooperVision inventory pressures, triggering a sharp share decline and investor scrutiny.
The lowered outlook and channel headwinds are likely to weigh on near-term sentiment and share performance
Similar Companies in Healthcare
Other companies in the same sector with AI ratings